National Comprehensive Cancer Network

Interactive CME


Educational Events & Programs

NCCN 11th Annual Congress:
Hematologic Malignancies™

New York, New York

Overview

Treatment of hematologic malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of breakthrough advances. In addition, targeted therapies and oral treatments bring the latest benefits to patients. This congress focuses on the new approaches that have been incorporated into patient management, including the use of drugs, biologics, and diagnostics.

Recorded Presentations
Earn up to 8.75 credits with recorded presentations from the NCCN 11th Annual Congress: Hematologic Malignancies™ that took place September 30 - October 1, 2016 in New York, NY.

Recorded Lunch Symposium – The Future of Targeted Therapies for Acute Myeloid Leukemia
Earn .75 credit! This activity is designed to address the unprecedented recent and ongoing advances in AML research and anticipated changes in the AML therapeutic landscape resulting from the development of many innovative therapies, several of which are in late stages of clinical trials.

For a complete list of available recordings from the NCCN 11th Annual Congress: Hematologic Malignancies, please visit education.nccn.org/hem2016.


Future Hematologic Malignancies Congress Dates:

  • NCCN 12th Annual Congress: Hematologic Malignancies™
    Friday, October 6, 2017 – Saturday, October 7, 2017
    Hilton San Francisco Union Square • San Francisco, California

Please check back often for the most up-to-date information. Please contact 866.788.NCCN (6226) or send an e-mail if you have additional questions.